Boguslawa Leja

Tyrosine Kinase Inhibitors. 6. Structure−Activity Relationships among <i>N</i>- and 3-Substituted 2,2‘-Diselenobis(1<i>H</i>-indoles) for Inhibition of Protein Tyrosine Kinases and Comparative <i>in Vitro</i> and <i>in Vivo</i> Studies against Selected Sulfur Congeners

H. D. Hollis Showalter, Anthony D. Sercel, Boguslawa Leja et al. · Journal of Medicinal Chemistry · 1997 · 64 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Chiral cynthesis of D- and L-3,3-diphenylalanine (DIP), unusual α-amino acids for peptides of biological interest

Huai G. Chen, V. G. BEYLIN, Mark E. Marlatt et al. · Tetrahedron Letters · 1992 · 33 citations

Pharmacy, Biochemistry, Medicinal Chemistry +15

Anticancer anthrapyrazoles. Improved syntheses of clinical agents CI‐937, CI‐941, and piroxantrone hydrochloride

V. G. BEYLIN, Norman L. Colbry, O. P. Goel et al. · Journal of Heterocyclic Chemistry · 1989 · 17 citations

Medicine, Medicinal Chemistry, Pharmacology +7

Anticancer anilinoacridines. A process synthesis of the disubstituted amsacrine analog CI‐921

Sean Brennan, Norman L. Colbry, Robert L. Leeds et al. · Journal of Heterocyclic Chemistry · 1989 · 15 citations

Medicine, Medicinal Chemistry, Pharmacology +5

An improved synthesis of anticancer benzothiopyranoindazoles. An efficient large‐scale β‐aminoethylation procedure

V. G. BEYLIN, Norman L. Colbry, Anne B. Giordani et al. · Journal of Heterocyclic Chemistry · 1991 · 10 citations

Pharmacy, Medicinal Chemistry, Oncology +9